Literature DB >> 21931291

Subcutaneous administration of muscarinic antagonists and triple-immunostaining of the levator auris longus muscle in mice.

Megan Wright1, Amy Kim, Young-Jin Son.   

Abstract

Hind limb muscles of rodents, such as gastrocnemius and tibialis anterior, are frequently used for in vivo pharmacological studies of the signals essential for the formation and maintenance of mammalian NMJs. However, drug penetration into these muscles after subcutaneous or intramuscular administration is often incomplete or uneven and many NMJs can remain unaffected. Although systemic administration with devices such as mini-pumps can improve the spatiotemporal effects, the invasive nature of this approach can cause confounding inflammatory responses and/or direct muscle damage. Moreover, complete analysis of the NMJs in a hind limb muscle is challenging because it requires time-consuming serial sectioning and extensive immunostaining. The mouse LAL is a thin, flat sheet of muscle located superficially on the dorsum of the neck. It is a fast-twitch muscle that functions to move the pinna. It contains rostral and caudal portions that originate from the midline of the cranium and extend laterally to the cartilaginous portion of each pinna. The muscle is supplied by a branch of the facial nerve that projects caudally as it exits the stylomastoid foramen. We and others have found LAL to be a convenient preparation that offers advantages for the investigation of both short and long-term in vivo effects of drugs on NMJs and muscles. First, its superficial location facilitates multiple local applications of drugs under light anesthesia. Second, its thinness (2-3 layers of muscle fibers) permits visualization and analysis of almost all the NMJs within the muscle. Third, the ease of dissecting it with its nerve intact together with the pattern of its innervation permits supplementary electrophysiological analysis in vitro. Last, and perhaps most importantly, a small applied volume (-50 μl) easily covers the entire muscle surface, provides a uniform and prolonged exposure of all its NMJs to the drug and eliminates the need for a systemic approach.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21931291      PMCID: PMC3230195          DOI: 10.3791/3124

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  13 in total

1.  Pre- and postsynaptic maturation of the neuromuscular junction during neonatal synapse elimination depends on protein kinase C.

Authors:  Maria A Lanuza; Neus Garcia; Manel Santafé; Carmen M González; Immaculada Alonso; Phillip G Nelson; Josep Tomàs
Journal:  J Neurosci Res       Date:  2002-03-01       Impact factor: 4.164

2.  Using mouse cranial muscles to investigate neuromuscular pathology in vivo.

Authors:  L M Murray; T H Gillingwater; S H Parson
Journal:  Neuromuscul Disord       Date:  2010-07-15       Impact factor: 4.296

3.  The levator auris longus muscle of the mouse: a convenient preparation for studies of short- and long-term presynaptic effects of drugs or toxins.

Authors:  D Angaut-Petit; J Molgo; A L Connold; L Faille
Journal:  Neurosci Lett       Date:  1987-11-10       Impact factor: 3.046

4.  Short-term effects of beta-amyloid25-35 peptide aggregates on transmitter release in neuromuscular synapses.

Authors:  Neus Garcia; Manel M Santafé; Marta Tomàs; Maria A Lanuza; Josep Tomàs
Journal:  J Neuropathol Exp Neurol       Date:  2008-03       Impact factor: 3.685

5.  Distinct patterns of motor nerve terminal sprouting induced by ciliary neurotrophic factor vs. botulinum toxin.

Authors:  Megan C Wright; Wha-Ja Cho; Young-Jin Son
Journal:  J Comp Neurol       Date:  2007-09-01       Impact factor: 3.215

6.  Induction of motor neuron sprouting in vivo by ciliary neurotrophic factor and basic fibroblast growth factor.

Authors:  M E Gurney; H Yamamoto; Y Kwon
Journal:  J Neurosci       Date:  1992-08       Impact factor: 6.167

7.  Ciliary neurotrophic factor is not required for terminal sprouting and compensatory reinnervation of neuromuscular synapses: re-evaluation of CNTF null mice.

Authors:  Megan C Wright; Young-Jin Son
Journal:  Exp Neurol       Date:  2007-03-21       Impact factor: 5.330

8.  Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Authors:  F Dörje; J Wess; G Lambrecht; R Tacke; E Mutschler; M R Brann
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

9.  Intrinsic neuronal determinants locally regulate extrasynaptic and synaptic growth at the adult neuromuscular junction.

Authors:  P Caroni; L Aigner; C Schneider
Journal:  J Cell Biol       Date:  1997-02-10       Impact factor: 10.539

10.  Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses.

Authors:  V Witzemann; H R Brenner; B Sakmann
Journal:  J Cell Biol       Date:  1991-07       Impact factor: 10.539

View more
  2 in total

1.  Dissection of the transversus abdominis muscle for whole-mount neuromuscular junction analysis.

Authors:  Lyndsay Murray; Thomas H Gillingwater; Rashmi Kothary
Journal:  J Vis Exp       Date:  2014-01-11       Impact factor: 1.355

2.  Sod1 gene ablation in adult mice leads to physiological changes at the neuromuscular junction similar to changes that occur in old wild-type mice.

Authors:  Maxim V Ivannikov; Holly Van Remmen
Journal:  Free Radic Biol Med       Date:  2015-04-02       Impact factor: 7.376

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.